Insider Transactions in Q4 2022 at Cin Cor Pharma, Inc. (CINC)
Insider Transaction List (Q4 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 28
2022
|
James Healy Director |
SELL
Open market or private sale
|
Indirect |
6,000
-100.0%
|
$84,000
$14.32 P/Share
|
|
Nov 04
2022
|
Michael Wayne Kalb EVP & Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
25,437
+50.0%
|
-
|